PTC Therapeutics Inc. (PTCT)
NASDAQ: PTCT
· Real-Time Price · USD
47.25
-0.61 (-1.27%)
At close: May 28, 2025, 3:59 PM
47.01
-0.51%
After-hours: May 28, 2025, 07:42 PM EDT
-1.27% (1D)
| Bid | 43.1 |
| Market Cap | 3.74B |
| Revenue (ttm) | 1.77B |
| Net Income (ttm) | 594.84M |
| EPS (ttm) | 6.51 |
| PE Ratio (ttm) | 7.26 |
| Forward PE | -17.14 |
| Analyst | Buy |
| Ask | 50 |
| Volume | 514,862 |
| Avg. Volume (20D) | 1,237,238 |
| Open | 47.89 |
| Previous Close | 47.86 |
| Day's Range | 47.15 - 48.19 |
| 52-Week Range | 28.72 - 58.38 |
| Beta | 0.52 |
About PTCT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PTCT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PTCT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+12.63%
PTC Therapeutics shares are trading higher after t...
Unlock content with
Pro Subscription
3 weeks ago
-18.62%
PTC Therapeutics shares are trading lower. The company announced results from the Phase 2 PIVOT-HD study of PTC518 in Stage 2 and Stage 3 Huntington's disease patients.
2 weeks ago · accessnewswire.com
Lost Money on PTC Therapeutics, Inc. (PTCT)? Possible Fraud - Contact Levi & Korsinsky TodayNEW YORK, NY / ACCESS Newswire / May 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of PTC Therapeutics, Inc. ("PTC Therapeutics, Inc.") (NASDAQ:PTCT) concerning...
